Ayala Pharmaceuticals Inc (ADXS)
0.555
0.00 (0.00%)
USD |
OTCM |
Apr 26, 15:38
Ayala Pharmaceuticals Shareholders Equity (Quarterly): -24.42M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -24.42M |
| September 30, 2023 | -6.241M |
| June 30, 2023 | 1.009M |
| December 31, 2022 | -1.099M |
| September 30, 2022 | 8.159M |
| June 30, 2022 | 17.36M |
| March 31, 2022 | 24.82M |
| December 31, 2021 | 34.16M |
| Date | Value |
|---|---|
| September 30, 2021 | 39.38M |
| June 30, 2021 | 42.76M |
| March 31, 2021 | 53.03M |
| December 31, 2020 | 38.40M |
| September 30, 2020 | 46.93M |
| June 30, 2020 | 53.96M |
| March 31, 2020 | -45.22M |
| December 31, 2019 | -38.92M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-45.22M
Minimum
Mar 2020
53.96M
Maximum
Jun 2020
15.25M
Average
21.09M
Median
Shareholders Equity (Quarterly) Benchmarks
| Taro Pharmaceutical Industries Ltd | 1.779B |
| InspireMD Inc | 39.50M |
| BiomX Inc | 3.081M |
| Alpha Tau Medical Ltd | 84.48M |
| Pluri Inc | 4.399M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 16.58M |
| Total Liabilities (Quarterly) | 41.00M |